BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Geisler S. Vincristine- and bortezomib-induced neuropathies - from bedside to bench and back. Exp Neurol 2021;336:113519. [PMID: 33129841 DOI: 10.1016/j.expneurol.2020.113519] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhong J, Yu W, Tang Y, Zhou X. Synchrotron Radiation FTIR Microspectroscopy Study of Biomolecular Alterations in Vincristine-Treated WRL68 Cells at the Single-Cell Level. ACS Omega 2022;7:47274-84. [PMID: 36570260 DOI: 10.1021/acsomega.2c06622] [Reference Citation Analysis]
2 Gomez-deza J, Slavutsky A, Nebiyou M, Pichon CL. Local production of reactive oxygen species drives vincristine-induced axon degeneration.. [DOI: 10.21203/rs.3.rs-2264669/v1] [Reference Citation Analysis]
3 Tsai N, Lin C, Yeh T, Chiu Y, Chiu H, Huang H, Hsieh S. An induced pluripotent stem cell-based model identifies molecular targets of vincristine neurotoxicity. Disease Models & Mechanisms 2022;15. [DOI: 10.1242/dmm.049471] [Reference Citation Analysis]
4 Gómez-deza J, Slavutsky AL, Nebiyou M, Le Pichon CE. Local production of reactive oxygen species drives vincristine-induced axon degeneration.. [DOI: 10.1101/2022.07.30.501173] [Reference Citation Analysis]
5 Cartelli D, Cavaletti G, Lauria G, Meregalli C. Ubiquitin Proteasome System and Microtubules Are Master Regulators of Central and Peripheral Nervous System Axon Degeneration. Cells 2022;11:1358. [DOI: 10.3390/cells11081358] [Reference Citation Analysis]
6 Was H, Borkowska A, Bagues A, Tu L, Liu JYH, Lu Z, Rudd JA, Nurgali K, Abalo R. Mechanisms of Chemotherapy-Induced Neurotoxicity. Front Pharmacol 2022;13:750507. [PMID: 35418856 DOI: 10.3389/fphar.2022.750507] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Vaxman I, Mauerman ML, Gatt ML, Berger T, Gertz MA. Foot drop in patients treated with bortezomib - a case series and review of the literature. Leuk Lymphoma 2021;:1-7. [PMID: 34702127 DOI: 10.1080/10428194.2021.1992758] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Li T, Mizrahi D, Goldstein D, Kiernan MC, Park SB. Chemotherapy and peripheral neuropathy. Neurol Sci 2021;42:4109-21. [PMID: 34436727 DOI: 10.1007/s10072-021-05576-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Herradón E, González C, González A, Uranga JA, López-Miranda V. Cardiovascular Toxicity Induced by Chronic Vincristine Treatment. Front Pharmacol 2021;12:692970. [PMID: 34366848 DOI: 10.3389/fphar.2021.692970] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Briani C, Ferrari S, Campagnolo M, Tagliapietra M, Castellani F, Salvalaggio A, Mariotto S, Visentin A, Cavallaro T. Mechanisms of Nerve Damage in Neuropathies Associated with Hematological Diseases: Lesson from Nerve Biopsies. Brain Sci 2021;11:132. [PMID: 33498362 DOI: 10.3390/brainsci11020132] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
11 Alberti P, Steer CB. Prevention of Chemotherapy-Induced Peripheral Neuropathy (CIPN): Current Clinical Data and Future Directions. Diagnosis, Management and Emerging Strategies for Chemotherapy-Induced Neuropathy 2021. [DOI: 10.1007/978-3-030-78663-2_5] [Reference Citation Analysis]